These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32777298)

  • 81. Comparing cytochrome P450 pharmacogenetic information available on United States drug labels and European Union Summaries of Product Characteristics.
    Reis-Pardal J; Rodrigues A; Rodrigues E; Fernandez-Llimos F
    Pharmacogenomics J; 2017 Dec; 17(6):488-493. PubMed ID: 27241061
    [TBL] [Abstract][Full Text] [Related]  

  • 82. An evidence-based approach for providing cautionary recommendations to sulfonamide-allergic patients and determining cross-reactivity among sulfonamide-containing medications.
    Ghimire S; Kyung E; Lee JH; Kim JW; Kang W; Kim E
    J Clin Pharm Ther; 2013 Jun; 38(3):196-202. PubMed ID: 23489131
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Importation of prescription medications: experiences, opinions, and intended behaviors of U.S. community pharmacists.
    Pickard AS; Nau DP; McKercher PL; Schumock GT
    J Am Pharm Assoc (2003); 2004; 44(6):666-72. PubMed ID: 15637849
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Determinants of the evolution of hospital pharmacy in France and Quebec: Perception of hospital pharmacists].
    Guérin A; Lebel D; Marando N; Prot-Labarthe S; Bourdon O; Bussières JF
    Ann Pharm Fr; 2014 May; 72(3):202-15. PubMed ID: 24780836
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Evaluation of knowledge and perceptions of pharmacists and residents pharmacists about bibliometric indicators applied to the scientific literature in pharmacy].
    Ferrand É; Odou P; Lebel D; Bussières JF
    Ann Pharm Fr; 2019 May; 77(3):250-263. PubMed ID: 30665679
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Pharmacogenomics in a community pharmacy: ACT now.
    Padgett L; O'Connor S; Roederer M; McLeod H; Ferreri S
    J Am Pharm Assoc (2003); 2011; 51(2):189-93. PubMed ID: 21382809
    [TBL] [Abstract][Full Text] [Related]  

  • 87. International Conference on Harmonisation; Guidance on E15 Pharmacogenomics Definitions and Sample Coding; Availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Apr; 73(68):19074-6. PubMed ID: 18677821
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM).
    Ansell J; Hollowell J; Pengo V; Martinez-Brotons F; Caro J; Drouet L
    J Thromb Thrombolysis; 2007 Apr; 23(2):83-91. PubMed ID: 17221328
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project.
    Pratt VM; Everts RE; Aggarwal P; Beyer BN; Broeckel U; Epstein-Baak R; Hujsak P; Kornreich R; Liao J; Lorier R; Scott SA; Smith CH; Toji LH; Turner A; Kalman LV
    J Mol Diagn; 2016 Jan; 18(1):109-23. PubMed ID: 26621101
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Prevalence and types of inconsistencies in clinical pharmacogenetic recommendations among major U.S. sources.
    Shugg T; Pasternak AL; London B; Luzum JA
    NPJ Genom Med; 2020; 5():48. PubMed ID: 33145028
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Unexpected High Need for Genetic Testing in Rheumatology: A Cross-Sectional Cohort Study.
    Kampik L; Schirmer M
    Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895207
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Pharmacogenetics for patient care in France: A discipline that evolves!].
    Barin-Le Guellec C; Picard N; Alarcan H; Barreau M; Becquemont L; Quaranta S; Boyer JC; Loriot MA;
    Therapie; 2020; 75(5):459-470. PubMed ID: 31767126
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Tertiary drug information sources for treatment and prevention of COVID-19.
    Beckett RD; Brattain Y; Truong J; Engle G
    J Med Libr Assoc; 2023 Oct; 111(4):783-791. PubMed ID: 37928123
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Acceptability of Pharmacogenetic Testing among French Psychiatrists, a National Survey.
    Laplace B; Calvet B; Lacroix A; Mouchabac S; Picard N; Girard M; Charles E
    J Pers Med; 2021 May; 11(6):. PubMed ID: 34064030
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Patients' Perceptions of Pharmacogenetic Testing and Access to Their Results: State of the Art in Spain and Systematic Review.
    Zubiaur P; Prósper-Cuesta DN; Novalbos J; Mejía-Abril G; Navares-Gómez M; Villapalos-García G; Soria-Chacartegui P; Abad-Santos F
    J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207758
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The Utility of Pharmacogenetics Testing in Psychiatric Populations.
    Jürgens G
    J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945734
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A Decade of Pharmacogenetic Studies in Jordan: A Systemic Review.
    Yehya A; Altaany Z
    Pharmacogenomics J; 2021 Oct; 21(5):543-550. PubMed ID: 33850297
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Standardization of genetic tests needed.
    Glauser W
    CMAJ; 2010 Oct; 182(15):E705-6. PubMed ID: 20855485
    [No Abstract]   [Full Text] [Related]  

  • 99. Pharmacogenetics raises new legal questions.
    Hutson S
    Nat Med; 2010 Jul; 16(7):729. PubMed ID: 20613735
    [No Abstract]   [Full Text] [Related]  

  • 100. Genetic Science is Brilliant - Can We Afford it?
    Alderman C
    Sr Care Pharm; 2021 Jun; 36(6):268-269. PubMed ID: 34016222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.